Characterization of anti-cerebroside sulfate antisera using a theoretical model to analyse liposome immune lysis data.
Antisera to the acidic glycolipid cerebroside sulfate (sulfogalactosyl ceramide) were raised in rabbits by several different methods. Reactivity with cerebroside sulfate was detected from complement-mediated lysis of liposomes composed of phosphatidylcholine/cholesterol/cerebroside sulfate and containing the spin label tempocholine chloride as a marker substance. Both cholesterol rich particles and lipid bilayer liposomes containing phosphatidylcholine and cholesterol were effective carriers for cerebroside sulfate, in combination with methylated bovine serum albumin for intravenous immunization, and with Freunds complete adjuvant for subcutaneous immunization. The antisera raised by the different methods were characterized with respect to their cross reactivity with other lipids and the relative concn of specific antibodies and their affinities for cerebroside sulfate using a theoretical model developed earlier [Vistnes A. I. (1984) J. Immun. Meth. 68, 251] for analysis of data from immune lysis of liposomes. Differences in these properties, both of which can affect antibody titer, could be detected for antisera raised by different methods and obtained at different times after immunization. Some of the antisera also reacted non-specifically to varying degrees with other anionic lipids indicating that the anti-cerebroside sulfate antibodies could bind non-specifically to anionic lipids by electrostatic interactions. This suggested that basic amino acid residues may be an important part of the antibody receptor binding site for the glycolipid head group. An important implication of this result is that antibodies raised against anionic glycolipids should be tested for non-specific binding to anionic phospholipids.
Department of Clinical Biochemistry, University of Toronto, Canada.
S J
SJ
Crook
R
R
Stewart
J M
JM
Boggs
A I
AI
Vistnes
B
B
Zalc
D000818:Animals; D002554:Cerebrosides / Q000276:immunology*; D003168:Complement Fixation Tests; D003165:Complement System Proteins / Q000276:immunology; D003429:Cross Reactions; D003497:Cyclic N-Oxides; D005699:Galactosylceramides / Q000276:immunology*; D007106:Immune Sera / Q000276:immunology*; D007118:Immunoassay / Q000379:methods; D008081:Liposomes / Q000276:immunology*; D008297:Male; D008954:Models, Biological; D011817:Rabbits; D013113:Spin Labels
D002554:Cerebrosides; D003497:Cyclic N-Oxides; D005699:Galactosylceramides; D007106:Immune Sera; D008081:Liposomes; D013113:Spin Labels; C017743:tempocholine; D003165:Complement System Proteins